Comments on: Fangda advises OTR Therapeutics in entering multi-program strategic collaboration and license agreement with Zealand Pharma to develop novel therapeutics for metabolic diseases

Comments on: Fangda advises OTR Therapeutics in entering multi-program strategic collaboration and license agreement with Zealand Pharma to develop novel therapeutics for metabolic diseases /press-release/fangda-otr-therapeutics-zealand-pharma-develop-novel-therapeutics-for-metabolic-diseases/ Wed, 24 Dec 2025 08:21:29 +0000 hourly 1